TY - JOUR
T1 - Prognostic Impact of Intra-abdominal/Pelvic Inflammation after Radical Surgery for Locally Recurrent Rectal Cancer
AU - Tanaka, Masahiro
AU - Kanemitsu, Yukihide
AU - Shida, Dai
AU - Ochiai, Hiroki
AU - Tsukamoto, Shunsuke
AU - Nagino, Masato
AU - Moriya, Yoshihiro
N1 - Publisher Copyright:
© 2017 The ASCRS.
PY - 2017/8/1
Y1 - 2017/8/1
N2 - Background: The influence of postoperative infectious complications, such as anastomotic leakage, on survival has been reported for various cancers, including colorectal cancer. However, it remains unclear whether intra-abdominal/pelvic inflammation after radical surgery for locally recurrent rectal cancer is relevant to its prognosis. Objective: The purpose of this study was to evaluate factors associated with survival after radical surgery for locally recurrent rectal cancer. Design: The prospectively collected data of patients were retrospectively evaluated. Settings: This study was conducted at a single-institution tertiary care cancer center. Patients: Between 1983 and 2012, patients who underwent radical surgery for locally recurrent rectal cancer with curative intent at the National Cancer Center Hospital were reviewed. Main Outcome Measures: Factors associated with overall and relapse-free survival were evaluated. RESULTS: During the study period, a total of 180 patients were eligible for analyses. Median blood loss and operation time for locally recurrent rectal cancer were 2022 mL and 634 minutes. Five-year overall and 3-year relapse-free survival rates were 38.6% and 26.7%. Age (p = 0.002), initial tumor stage (p = 0.03), pain associated with locally recurrent rectal cancer (p = 0.03), CEA level (p = 0.004), resection margin (p < 0.001), intra-abdominal/pelvic inflammation (p < 0.001), and surgery period (p = 0.045) were independent prognostic factors associated with overall survival, whereas CEA level (p = 0.01), resection margin (p = 0.002), and intra-abdominal/pelvic inflammation (p = 0.001) were associated with relapse-free survival. Intra-abdominal/pelvic inflammation was observed in 45 patients (25.0%). A large amount of perioperative blood loss was the only factor associated with the occurrence of intra-abdominal/pelvic inflammation (p = 0.007). Limitations: This study was limited by its retrospective nature and heterogeneous population. Conclusions: Intra-abdominal/pelvic inflammation after radical surgery for locally recurrent rectal cancer is associated with poor prognosis.
AB - Background: The influence of postoperative infectious complications, such as anastomotic leakage, on survival has been reported for various cancers, including colorectal cancer. However, it remains unclear whether intra-abdominal/pelvic inflammation after radical surgery for locally recurrent rectal cancer is relevant to its prognosis. Objective: The purpose of this study was to evaluate factors associated with survival after radical surgery for locally recurrent rectal cancer. Design: The prospectively collected data of patients were retrospectively evaluated. Settings: This study was conducted at a single-institution tertiary care cancer center. Patients: Between 1983 and 2012, patients who underwent radical surgery for locally recurrent rectal cancer with curative intent at the National Cancer Center Hospital were reviewed. Main Outcome Measures: Factors associated with overall and relapse-free survival were evaluated. RESULTS: During the study period, a total of 180 patients were eligible for analyses. Median blood loss and operation time for locally recurrent rectal cancer were 2022 mL and 634 minutes. Five-year overall and 3-year relapse-free survival rates were 38.6% and 26.7%. Age (p = 0.002), initial tumor stage (p = 0.03), pain associated with locally recurrent rectal cancer (p = 0.03), CEA level (p = 0.004), resection margin (p < 0.001), intra-abdominal/pelvic inflammation (p < 0.001), and surgery period (p = 0.045) were independent prognostic factors associated with overall survival, whereas CEA level (p = 0.01), resection margin (p = 0.002), and intra-abdominal/pelvic inflammation (p = 0.001) were associated with relapse-free survival. Intra-abdominal/pelvic inflammation was observed in 45 patients (25.0%). A large amount of perioperative blood loss was the only factor associated with the occurrence of intra-abdominal/pelvic inflammation (p = 0.007). Limitations: This study was limited by its retrospective nature and heterogeneous population. Conclusions: Intra-abdominal/pelvic inflammation after radical surgery for locally recurrent rectal cancer is associated with poor prognosis.
KW - Intra-abdominal/pelvic inflammation
KW - Prognosis
KW - Rectal cancer
KW - Recurrence
KW - Surgery
UR - http://www.scopus.com/inward/record.url?scp=85024908680&partnerID=8YFLogxK
U2 - 10.1097/DCR.0000000000000853
DO - 10.1097/DCR.0000000000000853
M3 - 記事
C2 - 28682968
AN - SCOPUS:85024908680
SN - 0012-3706
VL - 60
SP - 827
EP - 836
JO - Diseases of the Colon and Rectum
JF - Diseases of the Colon and Rectum
IS - 8
ER -